Si MS and Imagawa DK |
Prenylation inhibitors to treat proliferative renal disease. |
2000 |
Lancet |
pmid:10791545
|
Boon PJ et al. |
Cytotoxicity and biotransformation of the anticancer drug perillyl alcohol in PC12 cells and in the rat. |
2000 |
Toxicol. Appl. Pharmacol. |
pmid:10936079
|
Hudes GR et al. |
Phase I pharmacokinetic trial of perillyl alcohol (NSC 641066) in patients with refractory solid malignancies. |
2000 |
Clin. Cancer Res. |
pmid:10955786
|
Löw-Baselli A et al. |
Failure to demonstrate chemoprevention by the monoterpene perillyl alcohol during early rat hepatocarcinogenesis: a cautionary note. |
2000 |
Carcinogenesis |
pmid:11023545
|
Unlu S et al. |
Perillyl alcohol, an inhibitor of geranylgeranyl transferase, induces apoptosis of immortalized human vascular smooth muscle cells in vitro. |
2000 |
J. Cardiovasc. Pharmacol. |
pmid:10672871
|
Ripple GH et al. |
Phase I clinical and pharmacokinetic study of perillyl alcohol administered four times a day. |
2000 |
Clin. Cancer Res. |
pmid:10690515
|
Crowell PL |
Prevention and therapy of cancer by dietary monoterpenes. |
1999 |
J. Nutr. |
pmid:10082788
|
Ariazi EA et al. |
Activation of the transforming growth factor beta signaling pathway and induction of cytostasis and apoptosis in mammary carcinomas treated with the anticancer agent perillyl alcohol. |
1999 |
Cancer Res. |
pmid:10213501
|
Satomi Y et al. |
Induction of AP-1 activity by perillyl alcohol in breast cancer cells. |
1999 |
Carcinogenesis |
pmid:10506111
|
Ripple GH and Wilding G |
Drug development in prostate cancer. |
1999 |
Semin. Oncol. |
pmid:10597732
|